The concept of GH resistance and IGF-I deficiency is becoming more complex and cannot now be considered as a single clinical entity, but is a continuum of genetic, phenotypic, and biochemical abnormalities (24). The gene discussed is GH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.